176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.87%
Negative revenue growth while AMD stands at 1.96%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
3.04%
Gross profit growth at 75-90% of AMD's 3.91%. Bill Ackman would demand operational improvements to match competitor gains.
55.04%
Positive EBIT growth while AMD is negative. John Neff might see a substantial edge in operational management.
55.04%
Positive operating income growth while AMD is negative. John Neff might view this as a competitive edge in operations.
280.21%
Positive net income growth while AMD is negative. John Neff might see a big relative performance advantage.
333.33%
Positive EPS growth while AMD is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
333.33%
Positive diluted EPS growth while AMD is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
-6.68%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
88.98%
OCF growth above 1.5x AMD's 37.51%. David Dodd would confirm a clear edge in underlying cash generation.
58.42%
FCF growth above 1.5x AMD's 24.53%. David Dodd would verify if the firm’s strategic investments yield superior returns.
241.96%
10Y revenue/share CAGR above 1.5x AMD's 24.77%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
241.96%
5Y revenue/share CAGR above 1.5x AMD's 4.89%. David Dodd would look for consistent product or market expansions fueling outperformance.
116.71%
3Y revenue/share CAGR above 1.5x AMD's 20.31%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-116.65%
Negative 10Y OCF/share CAGR while AMD stands at 12.53%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-116.65%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-106.12%
Negative 3Y OCF/share CAGR while AMD stands at 194.20%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
53.94%
Positive 10Y CAGR while AMD is negative. John Neff might see a substantial advantage in bottom-line trajectory.
53.94%
Positive 5Y CAGR while AMD is negative. John Neff might view this as a strong mid-term relative advantage.
-22.07%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
684.61%
Positive growth while AMD is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
684.61%
5Y equity/share CAGR above 1.5x AMD's 22.28%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
159.52%
Positive short-term equity growth while AMD is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.58%
Our AR growth while AMD is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-10.19%
Inventory is declining while AMD stands at 8.37%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-4.07%
Negative asset growth while AMD invests at 7.71%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.11%
50-75% of AMD's 8.13%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-42.16%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.45%
Our R&D shrinks while AMD invests at 9.47%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
0.43%
SG&A declining or stable vs. AMD's 21.49%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.